These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708 [Abstract] [Full Text] [Related]
7. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Skomedal H, Kristensen GB, Lie AK, Holm R. Gynecol Oncol; 1999 May 15; 73(2):223-8. PubMed ID: 10329038 [Abstract] [Full Text] [Related]
9. Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status. Oh YL, Choi JS, Song SY, Ko YH, Han BK, Nam SJ, Yang JH. Pathol Int; 2001 Feb 15; 51(2):94-9. PubMed ID: 11169147 [Abstract] [Full Text] [Related]
10. Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors. Mouriaux F, Maurage CA, Labalette P, Sablonnière B, Malecaze F, Darbon JM. Invest Ophthalmol Vis Sci; 2000 Sep 15; 41(10):2837-43. PubMed ID: 10967035 [Abstract] [Full Text] [Related]
11. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma. Claudio PP, Zamparelli A, Garcia FU, Claudio L, Ammirati G, Farina A, Bovicelli A, Russo G, Giordano GG, McGinnis DE, Giordano A, Cardi G. Clin Cancer Res; 2002 Jun 15; 8(6):1808-15. PubMed ID: 12060621 [Abstract] [Full Text] [Related]
15. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder. Yurakh AO, Ramos D, Calabuig-Fariñas S, López-Guerrero JA, Rubio J, Solsona E, Romanenko AM, Vozianov AF, Pellin A, Llombart-Bosch A. Eur Urol; 2006 Sep 15; 50(3):506-15; discussion 515. PubMed ID: 16624482 [Abstract] [Full Text] [Related]
17. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM. Pathol Int; 2005 Feb 15; 55(2):53-62. PubMed ID: 15693850 [Abstract] [Full Text] [Related]
18. Inactivation of the p53 pathway in prostate cancer: impact on tumor progression. Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C. Clin Cancer Res; 1999 Aug 15; 5(8):2082-8. PubMed ID: 10473090 [Abstract] [Full Text] [Related]
19. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma. Bánkfalvi A, Tory K, Kemper M, Breukelmann D, Cubick C, Poremba C, Füzesi L, Lellè RJ, Böcker W. Pathol Res Pract; 2000 Aug 15; 196(7):489-501. PubMed ID: 10926327 [Abstract] [Full Text] [Related]